Dr Kathleen Campau

Senior Director Operations

Katie holds a Ph.D. in Cellular and Molecular Biology and has been involved in the field of genomics for the past 16 years. She joined LGC over seven years ago, starting as Senior Scientist with the Biosearch team based in Petaluma. Since then, Katie has successfully led teams in increasingly senior roles in both R&D and Operations.

Katie and her team played a key role in LGC’s covid-19 crisis response, including launch of the first assay in partnership with the US Centers for Disease Control & Prevention (CDC). They also partnered with key customers, including Abbott, to bring their covid products to fruition and keep pace with unrelenting global demand, as well as supporting the launch of LGC’s uHTP covid testing solution. Katie also led the program to build out ISO 13485 oligonucleotide production capacity across the Biosearch business, leading to facility expansions in the Petaluma and Lystrup, Denmark facilities. Most recently, Katie has co-led the creation of the strategy for Biosearch oligo business transformation.

Christine Perez

Director, Project Management

Christine has more than 20 years of experience in a CDMO environment supporting Nucleic Acids, Nucleoside Triphosphates and mRNA capping analog programs from ideation to commercialization.  

Christine joined the Axolabs division of LGC April 2022, leading the Project Management team. Christine previously served over 22 years at TriLink Biotechnologies leading the PMO, Continuous Improvement, Business Transformation Office and Operation Excellence division.